a consolidated net profit of THB 551 million, a decline of 18% QoQ and a decline of 75% YoY. Net profit attributable to owners of the parent was THB 370 million, and earnings per share was THB 0.27
decreased by 73% due to the decline of Availability Payment (AP) from the decrease in Weight factor. Furthermore, the reserve shutdown caused the decrease in revenue from Energy Payment (EP) which also caused
Ended December 31, 2018 To The President The Stock Exchange of Thailand Management Discussion and Analysis Consolidated Financial Statements For Financial Year ended December 31, 2018 Overall Group
IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
es from food Rental and mpany incu ore than the on and Analysi pany Limited nagement D sident Stock Exch Asset Public 2017, the e third quar auditor can erformance than the 3 mance for th month period
: 0107556000248 No. (SUTHA-SET) 030/2017/Eng 10 November 2017 Subject: Management Discussion and Analysis for period ended 30 September 2017 To: The President of the Stock Exchange of Thailand Attachment
duri es from food Rental and mpany incu ore than the on and Analysi pany Limited nagement D sident Stock Exch Asset Public 2017, the e third quar auditor can erformance e net loss mance for th month
Page 1 of 4 No. RJH – SET 10/2018 12 November 2018 Subject : Management Discussion and Analysis for the 3rd quarter of 2018 ending September 30, 2018 To : The President The Stock Exchange of Thailand